Lipid based nutrient supplements (LNS) for treatment of children (6 months to 59 months) with moderate acute malnutrition (MAM): A systematic review.

<h4>Background</h4>Moderate acute malnutrition is a major public health problem affecting children from low- and middle-income countries. Lipid nutrient supplements have been proposed as a nutritional intervention for its treatment.<h4>Objectives</h4>To evaluate the effective...

Full description

Saved in:
Bibliographic Details
Main Authors: Tarun Gera, Juan Pablo Pena-Rosas, Evelyn Boy-Mena, Harshpal S Sachdev
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0182096
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849682918440435712
author Tarun Gera
Juan Pablo Pena-Rosas
Evelyn Boy-Mena
Harshpal S Sachdev
author_facet Tarun Gera
Juan Pablo Pena-Rosas
Evelyn Boy-Mena
Harshpal S Sachdev
author_sort Tarun Gera
collection DOAJ
description <h4>Background</h4>Moderate acute malnutrition is a major public health problem affecting children from low- and middle-income countries. Lipid nutrient supplements have been proposed as a nutritional intervention for its treatment.<h4>Objectives</h4>To evaluate the effectiveness and safety of LNS for the treatment of MAM in infants and children 6 to 59 months of age.<h4>Study design</h4>Systematic review of randomized-controlled trials and controlled before-after studies.<h4>Results</h4>Data from nine trials showed that use of LNS, in comparison to specially formulated foods, improved the recovery rate (RR 1.08; 95% CI 1.02-1.14, 8 RCTs, 8934 participants, low quality evidence); decreased the chances of no recovery (RR 0.70; 95% CI 0.58-0.85, 7 RCTs, 8364 participants, low quality evidence) and the risk of deterioration into severe acute malnutrition (RR 0.87; 95% CI 0.73-1.03, 6 RCTs, 6788 participants, low quality evidence). There was little impact on mortality (RR 0.94, 95% CI 0.54-1.52, 8 RCTs, 8364 participants, very-low- quality evidence) or default rate (RR 1.32; 95% CI 0.73-2.4, 7 studies, 7570 participants, low quality evidence). There was improvement in weight gain, weight-for-height z-scores, height-for-age z-scores and mid-upper arm circumference. Subset analyses suggested higher recovery rates with greater amount of calories provided and with ready-to-use therapeutic foods, in comparison to ready-to-use supplementary foods. One study comparing LNS with nutritional counselling (very low quality evidence) showed higher chance of recovery, lower risk of deteriorating into severe acute malnutrition and lower default rate, with no impact on mortality, and no recovery.<h4>Conclusions</h4>Evidence restricted to the African regions suggests that LNS may be slightly more effective than specially formulated fortified foods or nutritional counselling in recovery from MAM, lowering the risk of deterioration into SAM, and improving weight gain with little impact on mortality or default rate.
format Article
id doaj-art-e657319c27a44fcab537e82aec1e107c
institution DOAJ
issn 1932-6203
language English
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-e657319c27a44fcab537e82aec1e107c2025-08-20T03:24:02ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01129e018209610.1371/journal.pone.0182096Lipid based nutrient supplements (LNS) for treatment of children (6 months to 59 months) with moderate acute malnutrition (MAM): A systematic review.Tarun GeraJuan Pablo Pena-RosasEvelyn Boy-MenaHarshpal S Sachdev<h4>Background</h4>Moderate acute malnutrition is a major public health problem affecting children from low- and middle-income countries. Lipid nutrient supplements have been proposed as a nutritional intervention for its treatment.<h4>Objectives</h4>To evaluate the effectiveness and safety of LNS for the treatment of MAM in infants and children 6 to 59 months of age.<h4>Study design</h4>Systematic review of randomized-controlled trials and controlled before-after studies.<h4>Results</h4>Data from nine trials showed that use of LNS, in comparison to specially formulated foods, improved the recovery rate (RR 1.08; 95% CI 1.02-1.14, 8 RCTs, 8934 participants, low quality evidence); decreased the chances of no recovery (RR 0.70; 95% CI 0.58-0.85, 7 RCTs, 8364 participants, low quality evidence) and the risk of deterioration into severe acute malnutrition (RR 0.87; 95% CI 0.73-1.03, 6 RCTs, 6788 participants, low quality evidence). There was little impact on mortality (RR 0.94, 95% CI 0.54-1.52, 8 RCTs, 8364 participants, very-low- quality evidence) or default rate (RR 1.32; 95% CI 0.73-2.4, 7 studies, 7570 participants, low quality evidence). There was improvement in weight gain, weight-for-height z-scores, height-for-age z-scores and mid-upper arm circumference. Subset analyses suggested higher recovery rates with greater amount of calories provided and with ready-to-use therapeutic foods, in comparison to ready-to-use supplementary foods. One study comparing LNS with nutritional counselling (very low quality evidence) showed higher chance of recovery, lower risk of deteriorating into severe acute malnutrition and lower default rate, with no impact on mortality, and no recovery.<h4>Conclusions</h4>Evidence restricted to the African regions suggests that LNS may be slightly more effective than specially formulated fortified foods or nutritional counselling in recovery from MAM, lowering the risk of deterioration into SAM, and improving weight gain with little impact on mortality or default rate.https://doi.org/10.1371/journal.pone.0182096
spellingShingle Tarun Gera
Juan Pablo Pena-Rosas
Evelyn Boy-Mena
Harshpal S Sachdev
Lipid based nutrient supplements (LNS) for treatment of children (6 months to 59 months) with moderate acute malnutrition (MAM): A systematic review.
PLoS ONE
title Lipid based nutrient supplements (LNS) for treatment of children (6 months to 59 months) with moderate acute malnutrition (MAM): A systematic review.
title_full Lipid based nutrient supplements (LNS) for treatment of children (6 months to 59 months) with moderate acute malnutrition (MAM): A systematic review.
title_fullStr Lipid based nutrient supplements (LNS) for treatment of children (6 months to 59 months) with moderate acute malnutrition (MAM): A systematic review.
title_full_unstemmed Lipid based nutrient supplements (LNS) for treatment of children (6 months to 59 months) with moderate acute malnutrition (MAM): A systematic review.
title_short Lipid based nutrient supplements (LNS) for treatment of children (6 months to 59 months) with moderate acute malnutrition (MAM): A systematic review.
title_sort lipid based nutrient supplements lns for treatment of children 6 months to 59 months with moderate acute malnutrition mam a systematic review
url https://doi.org/10.1371/journal.pone.0182096
work_keys_str_mv AT tarungera lipidbasednutrientsupplementslnsfortreatmentofchildren6monthsto59monthswithmoderateacutemalnutritionmamasystematicreview
AT juanpablopenarosas lipidbasednutrientsupplementslnsfortreatmentofchildren6monthsto59monthswithmoderateacutemalnutritionmamasystematicreview
AT evelynboymena lipidbasednutrientsupplementslnsfortreatmentofchildren6monthsto59monthswithmoderateacutemalnutritionmamasystematicreview
AT harshpalssachdev lipidbasednutrientsupplementslnsfortreatmentofchildren6monthsto59monthswithmoderateacutemalnutritionmamasystematicreview